CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Brincidofovir

布西多福韦 杂质对照品Brincidofovir Impurities

42 个杂质条目42 impurity entries

本页汇总 布西多福韦 的 42 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 42 impurity reference standards of Brincidofovir. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 布西多福韦(Brincidofovir)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsA quantitative LC-MS/MS method for the determination of tissue brincidofovir and cidofovir diphosphate in a MuPyV-infected mouse model
    Biomedical chromatography : BMC · 2021 · Guzman BB et al.  ·  PMID 33398885  ·  DOI
  2. 分析方法Analytical MethodsPeripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox
    Bioanalysis · 2024 · Hart R et al.  ·  PMID 39474814  ·  DOI

布西多福韦 —— 原料药与杂质对照品Brincidofovir — drug substance & impurities

共 43 个条目(含原料药本体)43 items incl. the drug substance
Brincidofovir structure
原料药 APIAPI
布西多福韦Brincidofovir
Brincidofovir
CAS No.444805-28-1
Chemical FormulaC27H52N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 1 structure
1
布西多福韦杂质1Brincidofovir Impurity 1
Brincidofovir Impurity 1
CAS No.4975-73-9
Chemical FormulaC17H31N3O
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir Impurity 2 Monomer structure
2
布西多福韦杂质2 单体Brincidofovir Impurity 2 Monomer
Brincidofovir Impurity 2 Monomer
CAS No.127757-45-3
Chemical FormulaC8H12N3O5P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 2 structure
2
布西多福韦杂质2Brincidofovir Impurity 2
Brincidofovir Impurity 2
CAS No.912635-37-1
Chemical FormulaC8H11N3O5P-·C17H32N3O+
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 3 structure
3
布西多福韦杂质3Brincidofovir Impurity 3
Brincidofovir Impurity 3
CAS No.126614-26-4
Chemical FormulaC19H39BrO
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 4 structure
4
布西多福韦杂质4Brincidofovir Impurity 4
Brincidofovir Impurity 4
CAS No.343248-25-9
Chemical FormulaC27H50N3O6P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 5 structure
5
布西多福韦杂质5Brincidofovir Impurity 5
Brincidofovir Impurity 5
CAS No.172405-52-6
Chemical FormulaC24H21N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 6 structure
6
布西多福韦杂质6Brincidofovir Impurity 6
Brincidofovir Impurity 6
CAS No.864068-43-9
Chemical FormulaC46H41N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 7 structure
7
布西多福韦杂质7Brincidofovir Impurity 7
Brincidofovir Impurity 7
CAS No.864068-45-1
Chemical FormulaC27H49O7PS
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 8 structure
8
布西多福韦杂质8Brincidofovir Impurity 8
Brincidofovir Impurity 8
CAS No.864068-46-2
Chemical FormulaC66H82N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 9 structure
9
布西多福韦杂质9Brincidofovir Impurity 9
Brincidofovir Impurity 9
CAS No.864068-44-0
Chemical FormulaC8H11O6PS·C5H5N
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 10 structure
10
布西多福韦杂质10Brincidofovir Impurity 10
Brincidofovir Impurity 10
CAS No.23377-40-4
Chemical FormulaC19H40O2
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 11 structure
11
布西多福韦杂质11Brincidofovir Impurity 11
Brincidofovir Impurity 11
CAS No.1431879-22-9
Chemical FormulaC11H20N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 12 structure
12
布西多福韦杂质12Brincidofovir Impurity 12
Brincidofovir Impurity 12
CAS No.718638-81-4
Chemical FormulaC29H56N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 13 structure
13
布西多福韦杂质13Brincidofovir Impurity 13
Brincidofovir Impurity 13
CAS No.718638-90-5
Chemical FormulaC31H60N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 14 structure
14
布西多福韦杂质14Brincidofovir Impurity 14
Brincidofovir Impurity 14
CAS No.956471-06-0
Chemical FormulaC28H54N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 15 structure
15
布西多福韦杂质15Brincidofovir Impurity 15
Brincidofovir Impurity 15
CAS No.956470-92-1
Chemical FormulaC31H60N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 16 structure
16
布西多福韦杂质16Brincidofovir Impurity 16
Brincidofovir Impurity 16
CAS No.1310218-81-5
Chemical FormulaC28H52N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 17 structure
17
布西多福韦杂质17Brincidofovir Impurity 17
Brincidofovir Impurity 17
CAS No.956471-42-4
Chemical FormulaC27H51FN3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 18 structure
18
布西多福韦杂质18Brincidofovir Impurity 18
Brincidofovir Impurity 18
CAS No.956575-37-4
Chemical FormulaC27H51FN3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 19 structure
19
布西多福韦杂质19Brincidofovir Impurity 19
Brincidofovir Impurity 19
CAS No.913356-60-2
Chemical FormulaC27H51FN3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 20 structure
20
布西多福韦杂质20Brincidofovir Impurity 20
Brincidofovir Impurity 20
CAS No.1025960-45-5
Chemical FormulaC34H58N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 21 structure
21
布西多福韦杂质21Brincidofovir Impurity 21
Brincidofovir Impurity 21
CAS No.849177-04-4
Chemical FormulaC34H58N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 22 structure
22
布西多福韦杂质22Brincidofovir Impurity 22
Brincidofovir Impurity 22
CAS No.718638-93-8
Chemical FormulaC36H62N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 23 structure
23
布西多福韦杂质23Brincidofovir Impurity 23
Brincidofovir Impurity 23
CAS No.1310058-50-4
Chemical FormulaC36H62N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 24 structure
24
布西多福韦杂质24Brincidofovir Impurity 24
Brincidofovir Impurity 24
CAS No.1621625-35-1
Chemical FormulaC34H56N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 25 structure
25
布西多福韦杂质25Brincidofovir Impurity 25
Brincidofovir Impurity 25
CAS No.1626364-31-5
Chemical FormulaC43H68N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 26 structure
26
布西多福韦杂质26Brincidofovir Impurity 26
Brincidofovir Impurity 26
CAS No.1362039-08-4
Chemical FormulaC46H66N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 27 structure
27
布西多福韦杂质27Brincidofovir Impurity 27
Brincidofovir Impurity 27
CAS No.1022982-83-7
Chemical FormulaC46H65FN3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 28 structure
28
布西多福韦杂质28Brincidofovir Impurity 28
Brincidofovir Impurity 28
CAS No.1621625-34-0
Chemical FormulaC53H70N3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 29 structure
29
布西多福韦杂质29Brincidofovir Impurity 29
Brincidofovir Impurity 29
CAS No.913356-58-8
Chemical FormulaC53H69FN3O8P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 30 structure
30
布西多福韦杂质30Brincidofovir Impurity 30
Brincidofovir Impurity 30
CAS No.1626364-32-6
Chemical FormulaC82H98N3O9P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 31 structure
31
布西多福韦杂质31Brincidofovir Impurity 31
Brincidofovir Impurity 31
CAS No.686777-26-4
Chemical FormulaC28H52N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 32 structure
32
布西多福韦杂质32Brincidofovir Impurity 32
Brincidofovir Impurity 32
CAS No.1348569-88-9
Chemical FormulaC28H52N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 33 structure
33
布西多福韦杂质33Brincidofovir Impurity 33
Brincidofovir Impurity 33
CAS No.1348452-76-5
Chemical FormulaC27H50N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 34 structure
34
布西多福韦杂质34Brincidofovir Impurity 34
Brincidofovir Impurity 34
CAS No.1348334-70-2
Chemical FormulaC27H50N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 35 structure
35
布西多福韦杂质35Brincidofovir Impurity 35
Brincidofovir Impurity 35
CAS No.959342-30-4
Chemical FormulaC28H52N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 36 structure
36
布西多福韦杂质36Brincidofovir Impurity 36
Brincidofovir Impurity 36
CAS No.2267985-40-8
Chemical FormulaC28H54N3O6PS2
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 37 structure
37
布西多福韦杂质37Brincidofovir Impurity 37
Brincidofovir Impurity 37
CAS No.693803-29-1
Chemical FormulaC29H54N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 38 structure
38
布西多福韦杂质38Brincidofovir Impurity 38
Brincidofovir Impurity 38
CAS No.686777-27-5
Chemical FormulaC29H54N3O7P
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 39 structure
39
布西多福韦杂质39Brincidofovir Impurity 39
Brincidofovir Impurity 39
CAS No.916313-26-3
Chemical FormulaC28H55N3O9P2
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir  Impurity 40 structure
40
布西多福韦杂质40Brincidofovir Impurity 40
Brincidofovir Impurity 40
CAS No.916313-25-2
Chemical FormulaC27H53N3O9P2
Purity>95%询价On request
10mg25mg50mg100mg
Brincidofovir Impurity 41 (1-Nonadecanol) structure
41
布西多福韦杂质41 (十九烷醇)Brincidofovir Impurity 41 (1-Nonadecanol)
Brincidofovir Impurity 41 (1-Nonadecanol)
CAS No.1454-84-8
Chemical FormulaC19H40O
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

For formulation & analytical R&D

布西多福韦 杂质谱研究要点Brincidofovir — impurity profiling notes

下面这些是拿到 布西多福韦 的 43 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 43 impurity entries for Brincidofovir, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances